Fairness Opinion

Duff & Phelps Advised the Special Committee of the Board of Directors of Xtant Medical Holdings, Inc. (NYSE American: XTNT) in Its Debt Restructuring Transaction

Xtant Medical
/-/media/assets/images/transactions/2020/xtant-medical.jpg

has completed a debt for equity exchange as part of a restructuring transaction

2020-08-12T00:00:00.0000000
Connect with us
Sheryl Cefali
Sheryl Cefali
Managing Director
Fairness and Solvency Opinions
Los Angeles
Phone

On August 10, 2020, Xtant Medical Holdings, Inc. (NYSE American: XTNT) ("the Company"), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has entered into a Restructuring and Exchange Agreement with the lenders under its credit facility to restructure Xtant’s outstanding indebtedness, including the exchange of certain indebtedness outstanding under the facility, together with accrued and unpaid interest thereon, into shares of Xtant common stock.

The primary purpose of the restructuring is to improve Xtant’s capital structure by reducing its outstanding debt, which the Company expects will facilitate future access to capital markets for investment in its growth initiatives, and provide a path to possibly regain compliance with the NYSE American continued listing standards.

Duff & Phelps served as a financial advisor to the special committee of the board of directors of Xtant Medical Holdings, Inc.and provided a fairness opinion in connection with the transaction.

About Xtant Medical Holdings, Inc. 
Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Fox Rothschild LLP served as legal counsel to Xtant Medical Holdings, Inc. and Stoel Rives LLP served as legal counsel to the special committee.


{1F8452CE-BB02-4541-A705-86D25933687E} {CA601B88-1E91-4803-A6A4-ECC35D220DCC} {22071366-6F45-4C04-8261-CDFA24749510} {A60877A4-2248-456C-B8DE-728B8C4124FC} {170088C8-830B-4C38-BC1D-E375A677EEDC} {C6E677F2-B5B4-485D-AA0E-9FBAA922A793} {2DEEE4D2-8278-4C50-B3FF-1563BB257804} /en/transactions/fairness-opinions/fairness-opinion-xtant-medical-holdings-inc case study

Stay Ahead with Kroll

Corporate Finance and Restructuring

Comprehensive investment banking, corporate finance, restructuring and insolvency services to investors, asset managers, companies and lenders.

Fairness and Solvency Opinions

Duff & Phelps Opinions practice helps boards of directors and special committees formed by boards fulfill their fiduciary responsibilities when considering many corporate transactions.

M&A Advisory

Kroll Corporate Finance supports companies and their advisors through every stage of M&A.

Transaction Advisory Services

Kroll’s Transaction Advisory Services is unencumbered by audit independence concerns and offers seamless analytical service throughout the deal continuum.

Private Capital Markets – Debt Advisory

Kroll has extensive experience raising capital for middle-market companies to support a wide range of transactions.

Fairness Opinion
Dating App Grindr Is Set to Go Public Via a De-SPAC Transaction Valued at $2.1 Billion. The Duff & Phelps Opinions Practice of Kroll Rendered a Fairness Opinion to Tiga Acquisition Corp. in Connection with Its Proposed Merger with Grindr Group, LLC.
Jun 07, 2022
Fairness Opinion Grindr
Dating App Grindr Is Set to Go Public Via a De-SPAC Transaction Valued at $2.1 Billion. The Duff & Phelps Opinions Practice of Kroll Rendered a Fairness Opinion to Tiga Acquisition Corp. in Connection with Its Proposed Merger with Grindr Group, LLC.